In this episode, Vic Gatto and guest host Rick Abramson, a physician and healthcare strategist, cover the latest in AI regulation, economic indicators affecting healthcare, recent venture deals in senior living and food-as-medicine startups, and growing momentum behind the MAHA (Make America Healthy Again) movement. They discuss controversial federal appointments, shifts in FDA policy, the balance between prevention and treatment, Medicare Advantage fraud allegations, state Medicaid funding loopholes, drug manufacturing regulation, and pressures facing the nursing workforce and academic medical centers.

Previous Guest Show:

#73 - AI and Healthcare Innovation: A Conversation with Dr. Rick Abramson YouTube

Links

3:27 - U.S. nonfarm jobs grow by 177,000 in April, beating expectations UPI

4:28 - Powell rules out a preemptive rate cut to blunt any tariff impact CNBC

6:12 - U.S. and U.K. Unveil Framework for Trade Deal WSJ

7:09 - U.S. and Chinese Officials to Meet for Trade Talks WSJ

8:08 - TSOLife Secures $43M to Revolutionize Senior Living Experience HIT

10:11 - FoodHealth Company corrals $7.5M Series A to support pivot Axios

12:03 - Deerfield Management raises $600M fund in "constrained" market Axios

12:53 - Trump Picks a ‘MAHA’ Movement Leader for Surgeon General WSJ

13:38 - Biotech Stocks Fall After FDA Names Vinay Prasad To Succeed Marks at CBER BioSpace

[ENG] Why raising MONEY in Italy is so HARD for STARTUPS

Actually

Come EU Inc. semplifica struttura legale e investimenti

The AI-powered Podcast Player